Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Issue of Equity

16 May 2007 16:17

Phorm Inc16 May 2007 16 May 2007 Phorm, Inc. ("Phorm" or the "Company") Additional Listing The Company (AIM: PHRM and PHRX) announces that, following the exercise of26,473 warrants by ex-advisers to the Company, it has issued, conditional onadmission, 26,473 common shares of $0.001 each. Application has been made for the 26,473 common shares to be admitted to tradingon AIM and dealings are expected to commence on 22 May 2007. Following the issue of these shares the Company will have 11,419,284 votingCommon Shares in issue, none of which are in treasury. For enquiries: Phorm, Inc. Kent Ertugrul (Chief Executive) Tel: + 44 (0)870 405 7722 Canaccord Adams Mark Williams / Andrew Chubb Tel: +44 (0)20 7050 6500 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.